17 June 2026 Price Sensitive Announcement $ Highlights: Overview: Neurizon Therapeutics has taken a significant step toward commercialisation readiness for its lead asset NUZ-001, executing a long-term supply agreement with Elanco...
26 May 2026 Price Sensitive Announcement $ Highlights: Overview: Noxopharm Limited, a clinical-stage biotech company focused on developing novel immune-modulating therapies, is pleased to announce new data demonstrating how the Sofra™...
15 May 2025 Price Sensitive Announcement $ Highlights: Overview: Elixinol Wellness Limited (ASX: EXL), a leading sustainable nutrition and wellness company, is pleased to announce that its premium wellness brand, The...
